MintNeuro raises $5 million to supply purpose-built chips to neural device makers
MintNeuro, a London semiconductor company spun out of Imperial College London, announced a $5 million round on 7 October 2026 led by Odyssey Ventures, with 33East, JSK Investments and Alumni Ventures joining and Empirical Ventures, Jumpspace Ventures and other early investors investing again. It designs modular chips for neural sensing, signal processing and stimulation that device makers can build on in place of adapted general-purpose components or years of custom chip design. Its partners include Motif Neurotech, which announced a multi-year chip supply agreement with MintNeuro on 30 April for its depression implant, and Amber Therapeutics, whose co-founder Tim Denison chairs MintNeuro. The money will fund product launches, delivery of pre-release chips to partners, a larger team and a stronger US presence. MintNeuro's last disclosed equity round was £1 million in November 2024.